Ennogen Healthcare International Limited is a private limited company located at Unit G4 Riverside Industrial Estate, Riverside Way, Dartford DA1 5BS. Its net worth is estimated to be roughly 0 pounds, and the fixed assets the company owns amount to 0 pounds. Incorporated on 2020-12-23, this 3-year-old company is run by 2 directors.
Director Jason T., appointed on 14 June 2022. Director Gurdev R., appointed on 23 December 2020.
The company is classified as "wholesale of pharmaceutical goods" (SIC code: 46460), "manufacture of basic pharmaceutical products" (SIC code: 21100).
The latest confirmation statement was filed on 2022-12-22 and the due date for the next filing is 2024-01-05. Moreover, the annual accounts were filed on 31 December 2021 and the next filing is due on 31 December 2023.
Office Address | Unit G4 Riverside Industrial Estate |
Office Address2 | Riverside Way |
Town | Dartford |
Post code | DA1 5BS |
Country of origin | United Kingdom |
Registration Number | 13097275 |
Date of Incorporation | Wed, 23rd Dec 2020 |
Industry | Wholesale of pharmaceutical goods |
Industry | Manufacture of basic pharmaceutical products |
End of financial Year | 31st December |
Company age | 4 years old |
Account next due date | Sun, 31st Dec 2023 (128 days after) |
Account last made up date | Fri, 31st Dec 2021 |
Next confirmation statement due date | Fri, 5th Jan 2024 (2024-01-05) |
Last confirmation statement dated | Thu, 22nd Dec 2022 |
The list of persons with significant control who own or control the company consists of 2 names. As we established, there is Ennogen Investments Ltd from Dartford, England. This PSC is categorised as "a private limited company" and has 75,01-100% shares. This PSC and has 75,01-100% shares. The second one in the PSC register is Gurdev R. This PSC owns 75,01-100% shares.
Ennogen Investments Ltd
Unit G4 Riverside Way, Dartford, DA1 5BS, England
Legal authority | Companies Act 2006 |
Legal form | Private Limited Company |
Notified on | 1 January 2022 |
Nature of control: |
75,01-100% shares |
Gurdev R.
Notified on | 23 December 2020 |
Ceased on | 1 January 2022 |
Nature of control: |
75,01-100% shares |
Profit & Loss | ||
---|---|---|
Accounts Information Date | 2021-12-31 | 2022-12-31 |
Balance Sheet | ||
Cash Bank On Hand | 5 040 859 | |
Current Assets | 1 000 | 13 686 330 |
Debtors | 1 000 | 2 738 050 |
Net Assets Liabilities | 1 000 | 60 916 028 |
Other Debtors | 1 000 | 936 694 |
Property Plant Equipment | 17 249 | |
Total Inventories | 5 907 421 | |
Other | ||
Audit Fees Expenses | 7 500 | |
Accrued Liabilities Deferred Income | 56 774 | |
Accumulated Amortisation Impairment Intangible Assets | 2 533 364 | |
Accumulated Depreciation Impairment Property Plant Equipment | 1 363 | |
Additions Other Than Through Business Combinations Intangible Assets | 51 239 059 | |
Additions Other Than Through Business Combinations Property Plant Equipment | 18 612 | |
Administrative Expenses | 4 945 186 | |
Amortisation Expense Intangible Assets | 2 533 364 | |
Amounts Owed By Group Undertakings | 1 713 303 | |
Amounts Owed To Group Undertakings | 1 499 914 | |
Applicable Tax Rate | 19 | |
Average Number Employees During Period | 39 | |
Cash Cash Equivalents Cash Flow Value | 5 040 859 | |
Cash Flows Used In Acquiring Or Obtaining Control Subsidiaries Or Other Businesses Classified As Investing Activities | 1 | |
Comprehensive Income Expense | -1 484 972 | |
Corporation Tax Payable | 76 957 | |
Cost Sales | 2 511 287 | |
Creditors | 1 764 712 | |
Current Tax For Period | 76 957 | |
Depreciation Expense Property Plant Equipment | 1 363 | |
Distribution Costs | 561 385 | |
Finished Goods | 5 907 421 | |
Fixed Assets | 48 994 410 | |
Gain Loss In Cash Flows From Change In Accrued Items | 56 774 | |
Gain Loss In Cash Flows From Change In Creditors Trade Other Payables | 131 067 | |
Gain Loss In Cash Flows From Change In Debtors Trade Other Receivables | -1 000 | -2 737 050 |
Gain Loss In Cash Flows From Change In Inventories | -5 907 421 | |
Gain Loss On Non-financing Activities Due To Foreign Exchange Differences Recognised In Profit Or Loss | 415 | |
Gross Profit Loss | 4 092 027 | |
Income Expense Recognised Directly In Equity | 1 000 | 62 400 000 |
Increase Decrease In Cash Cash Equivalents Before Foreign Exchange Differences Changes In Consolidation | 5 040 859 | |
Increase Decrease In Net Debt From Cash Flows | 3 540 945 | |
Increase From Amortisation Charge For Year Intangible Assets | 2 533 364 | |
Increase From Depreciation Charge For Year Property Plant Equipment | 1 363 | |
Intangible Assets | 48 705 695 | |
Intangible Assets Gross Cost | 51 239 059 | |
Interest Income On Bank Deposits | 7 619 | |
Interest Paid Classified As Operating Activities | 1 090 | |
Interest Payable Similar Charges Finance Costs | 1 090 | |
Interest Received Classified As Operating Activities | 7 619 | |
Investments | 271 466 | |
Investments Fixed Assets | 271 466 | |
Investments In Group Undertakings | 1 | |
Issue Equity Instruments | 1 000 | 62 400 000 |
Net Cash Flows From Used In Financing Activities | 1 000 | 63 899 914 |
Net Cash Flows From Used In Investing Activities | -51 529 137 | |
Net Cash Flows From Used In Operating Activities | -1 000 | -7 329 918 |
Net Current Assets Liabilities | 1 000 | 11 921 618 |
Net Debt Funds | -3 540 945 | |
Operating Profit Loss | -1 414 544 | |
Other Creditors | 12 938 | |
Other Finance Costs | 1 090 | |
Other Interest Receivable Similar Income Finance Income | 7 619 | |
Other Investments Other Than Loans | 271 465 | |
Other Taxation Social Security Payable | 74 065 | |
Par Value Share | 1 | 1 |
Pension Costs Defined Contribution Plan | 36 136 | |
Pension Other Post-employment Benefit Costs Other Pension Costs | 36 136 | |
Prepayments Accrued Income | 88 053 | |
Proceeds From Issuing Shares | 1 000 | 62 400 000 |
Proceeds From Repayment Loans Advances To Group Undertakings Classified As Financing Activities | 1 499 914 | |
Profit Loss | -1 484 972 | |
Profit Loss On Ordinary Activities Before Tax | -1 408 015 | |
Property Plant Equipment Gross Cost | 18 612 | |
Purchase Intangible Assets | 51 239 059 | |
Purchase Property Plant Equipment | 18 612 | |
Research Development Expense Recognised In Profit Or Loss | 466 121 | |
Revenue From Sale Goods | 6 603 314 | |
Social Security Costs | 66 103 | |
Staff Costs Employee Benefits Expense | 789 055 | |
Tax Expense Credit Applicable Tax Rate | -267 523 | |
Tax Increase Decrease From Effect Capital Allowances Depreciation | 343 359 | |
Tax Increase Decrease From Effect Expenses Not Deductible In Determining Taxable Profit Or Loss | 1 121 | |
Tax Tax Credit On Profit Or Loss On Ordinary Activities | 76 957 | |
Total Assets Less Current Liabilities | 1 000 | 60 916 028 |
Trade Creditors Trade Payables | 44 064 | |
Turnover Revenue | 6 603 314 | |
Wages Salaries | 686 816 | |
Company Contributions To Money Purchase Plans Directors | 2 420 | |
Director Remuneration | 24 367 | |
Director Remuneration Benefits Excluding Payments To Third Parties | 26 787 | |
Called Up Share Capital Not Paid Not Expressed As Current Asset | 1 000 | |
Number Shares Allotted | 1 000 |
Type | Category | Free download | |
---|---|---|---|
CS01 |
Confirmation statement with updates 2023-12-22 filed on: 17th, January 2024 |
confirmation statement | Free Download (4 pages) |
© bizstats.co.uk 2024.
Terms of Use and Privacy Policy